|
|
DeciZen
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
Q
V
PT
|
230 Small Cap |
11.85 (0.00%) |
N/A | 0.4 | -6.71 | -232.05 |
|
|
| 2 |
Q
V
PT
|
1,340 Small Cap |
14.25 (0.00%) |
17.62 | 3.25 | 17.63 | 21.67 |
|
|
| 3 |
Q
V+
PT
|
879 Small Cap |
23 (0.00%) |
N/A | 1.85 | 24.05 | 7.49 |
|
|
| 4 |
Q
V
PT
|
2,558 Small Cap |
39.08 (0.00%) |
N/A | 8.19 | 96.10 | 0.00 |
|
|
| 5 |
Q
V
PT
|
3,272 Small Cap |
59.71 (0.00%) |
49.53 | 2.63 | 14.44 | 19.03 |
|
|
| 6 |
Q
V
PT
|
817 Small Cap |
81.49 (0.00%) |
19.9 | 2.32 | 16.60 | 20.73 |
|
|
| 7 |
Q
V
PT
|
1,097 Small Cap |
119.15 (0.00%) |
N/A | 4.09 | 15.00 | 7.68 |
|
|
| 8 |
Q
V+
PT
|
1,033 Small Cap |
131 (0.00%) |
104.32 | 4.19 | 0.00 | 0.00 |
|
|
| 9 |
Q
V
PT
|
2,179 Small Cap |
133.60 (0.00%) |
N/A | N/A | 19.21 | 12.72 |
|
|
| 10 |
Q
V+
PT
|
4,409 Small Cap |
150.20 (0.00%) |
32.03 | 2.45 | 0.00 | 0.00 |
|
|
| 11 |
Q
V
PT
|
1,284 Small Cap |
156.45 (0.00%) |
30.41 | 4.76 | 13.96 | 24.04 |
|
|
| 12 |
Q
V
PT
|
719 Small Cap |
161.75 (0.00%) |
29.65 | 1.84 | 0.00 | 0.00 |
|
|
| 13 |
Q
V
PT
|
22,393 Small Cap |
168.20 (0.00%) |
31.99 | 2.75 | 0.00 | 0.00 |
|
|
| 14 |
Q
V
PT
|
1,873 Small Cap |
173.45 (0.00%) |
16.59 | 1.5 | 12.52 | 25.39 |
|
|
| 15 |
Q
V
PT
|
903 Small Cap |
186.95 (0.00%) |
29.69 | 2.02 | 8.61 | 14.34 |
|
|
| 16 |
Q
V+
PT
|
2,948 Small Cap |
188 (0.00%) |
30.25 | 0.44 | 5.82 | -33.01 |
|
|
| 17 |
Q
V+
PT
|
2,751 Small Cap |
223.15 (0.00%) |
N/A | 2.3 | 4.29 | -1.50 |
|
|
| 18 |
Q
V
PT
|
1,236 Small Cap |
224.85 (0.00%) |
75.23 | 5 | 0.00 | 0.00 |
|
|
| 19 |
Q
V+
PT
|
1,548 Small Cap |
235.20 (0.00%) |
35.94 | 6.52 | 11.13 | 39.15 |
|
|
| 20 |
Q
V+
PT
|
7,759 Small Cap |
239.10 (0.00%) |
5 | 5.82 | -1.35 | 0.00 |
|
|
| 21 |
Q
V+
PT
|
2,246 Small Cap |
243.35 (0.00%) |
N/A | 2.04 | 6.54 | -182.78 |
|
|
| 22 |
Q
V
PT
|
4,103 Small Cap |
259.15 (0.00%) |
39.66 | 4.72 | 10.15 | 32.48 |
|
|
| 23 |
Q
V+
PT
|
1,416 Small Cap |
266.05 (0.00%) |
62.47 | 2.1 | 12.30 | -1.67 |
|
|
| 24 |
Q
V+
PT
|
12,102 Small Cap |
267.05 (0.00%) |
40.25 | 7.32 | 22.06 | 32.86 |
|
|
| 25 |
Q
V
PT
|
1,413 Small Cap |
271.30 (0.00%) |
43.9 | 5.77 | 9.86 | -51.00 |
|
|
| 26 |
Q
V+
PT
|
1,002 Small Cap |
286.85 (0.00%) |
15.15 | 6.94 | 10.29 | 30.27 |
|
|
| 27 |
Q
V+
PT
|
12,442 Small Cap |
288.05 (0.00%) |
339.79 | 14.47 | 0.00 | 0.00 |
|
|
| 28 |
Q
V
PT
|
12,772 Small Cap |
292.35 (0.00%) |
72.04 | 4.39 | 5.64 | -18.41 |
|
|
| 29 |
Q
V+
PT
|
7,884 Small Cap |
298.65 (0.00%) |
N/A | 5.24 | -14.30 | 0.00 |
|
|
| 30 |
Q
V
PT
|
989 Small Cap |
311 (0.00%) |
N/A | 3.65 | 109.54 | -201.92 |
|
|
| Rank | Company | Market Capitalization 2026 (INR crores) |
|---|---|---|
| 1 | Nectar Lifesciences Ltd. | 230 Crore |
| 2 | Syncom Formulations (India) Ltd. | 1,340 Crore |
| 3 | Sigachi Industries Ltd. | 879 Crore |
| 4 | Fischer Medical Ventures Ltd. | 2,558 Crore |
| 5 | Morepen Laboratories Ltd. | 3,272 Crore |
| 6 | Anuh Pharma Ltd. | 817 Crore |
| 7 | Themis Medicare Ltd. | 1,097 Crore |
| 8 | Gujarat Kidney And Super Speciality Ltd. | 1,033 Crore |
| 9 | KMC Speciality Hospitals (India) Ltd. | 2,179 Crore |
| 10 | IOL Chemicals And Pharmaceuticals Ltd. | 4,409 Crore |
You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.
Based on ROE, the best stocks in the Nifty Pharma companies index are:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | ROE |
|---|---|---|---|---|---|---|---|
| Abbott India Ltd. (M) | Very Good | 25,722 | 54,657 | 35.22 | 11.45 | 24.04 | 35.71 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,663 | 1,57,804 | 72.94 | 18.81 | 38.40 | 29.04 |
| Ajanta Pharma Ltd. (M) | Very Good | 3,344 | 41,776 | 39.56 | 9.23 | 26.73 | 25.35 |
| Lupin Ltd. (M) | Somewhat Good | 2,399 | 1,09,676 | 20.57 | 4.89 | 11.90 | 20.83 |
| Zydus Lifesciences Ltd. (M) | Very Good | 1,100 | 1,09,691 | 21.76 | 4.22 | 13.36 | 20.74 |
Based on the past year's gain, the best performing stocks are:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | Yearly gain (%) |
|---|---|---|---|---|
| Laurus Labs Ltd. (M) | Very Good | 1,525 | 82,399 | 101 |
| JB Chemicals & Pharmaceuticals Ltd. (S) | Very Good | 2,318 | 37,225 | 41.28 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,663 | 1,57,804 | 39.25 |
| Aurobindo Pharma Ltd. (M) | Very Good | 1,560 | 89,762 | 34.75 |
| Ajanta Pharma Ltd. (M) | Very Good | 3,344 | 41,776 | 31.18 |
| View More |
Stocks with the highest revenue growth in the past 5 years is:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | 5Y Sales Growth (%) |
|---|---|---|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals Ltd. (S) | Very Good | 2,318 | 37,225 | 55.22 | 9.22 | 33.44 | 15.51 |
| Mankind Pharma Ltd. (M) | Very Good | 2,487 | 1,02,729 | 50.42 | 6.27 | 31.67 | 14.65 |
| Ajanta Pharma Ltd. (M) | Very Good | 3,344 | 41,776 | 39.56 | 9.23 | 26.73 | 13.54 |
| Dr. Reddys Laboratories Ltd. (M) | Very Good | 1,346 | 1,12,368 | 26.78 | 2.98 | 14.95 | 12.09 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,663 | 1,57,804 | 72.94 | 18.81 | 38.40 | 11.80 |
Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.
Stocks with the highest profit growth in the past 5 years is:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | 5Y Profit Growth (%) |
|---|---|---|---|---|---|---|---|
| Zydus Lifesciences Ltd. (M) | Very Good | 1,100 | 1,09,691 | 21.76 | 4.22 | 13.36 | 30.57 |
| Sun Pharmaceutical Industries Ltd. (L) | Very Good | 1,872 | 4,49,048 | 39.12 | 5.37 | 22.41 | 23.50 |
| Abbott India Ltd. (M) | Very Good | 25,722 | 54,657 | 35.22 | 11.45 | 24.04 | 18.78 |
| Dr. Reddys Laboratories Ltd. (M) | Very Good | 1,346 | 1,12,368 | 26.78 | 2.98 | 14.95 | 15.75 |
| Glenmark Pharmaceuticals Ltd. (M) | Very Good | 2,195 | 61,943 | 45.48 | 5.89 | 12.07 | 14.41 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: